PAMU
KRON

Pictet Asset Management (UK)’s Kronos Bio KRON Stock Holding History

Pictet Asset Management (UK)’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.61M Buy
109,063
+6,434
+6% +$163K ﹤0.01% 967
2021
Q1 		$3M Buy
102,629
+4,720
+5% +$138K ﹤0.01% 932
2020
Q4 		$2.92M Buy
+97,909
New +$3.07M ﹤0.01% 925

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Pictet Asset Management (UK)'s KRON Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Kronos Bio (KRON) stake by 6.3% in Q2 2021, buying an estimated $163K and bringing the position to 109,063 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #967.

Pictet Asset Management (UK) first reported a position in KRON in Q4 2020 and has held it in 3 quarters since. The position peaked at $3M in Q1 2021. 77 funds tracked by Wall St. Rank hold KRON as of Q2 2021.

  • Pictet Asset Management (UK) held 109,063 shares of Kronos Bio worth $2.61M as of Q2 2021.
  • Pictet Asset Management (UK) bought 6,434 Kronos Bio shares in Q2 2021, an estimated $163K.
  • Kronos Bio made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #967 holding.
  • Pictet Asset Management (UK) first reported a position in Kronos Bio in Q4 2020 and has held it in 3 quarters since.
  • Pictet Asset Management (UK)'s Kronos Bio position peaked at $3M in Q1 2021.
  • 77 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.